{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T22:40:27Z","timestamp":1790635227699,"version":"4.1.0"},"reference-count":36,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"31","license":[{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2025,8,1]]},"abstract":"<jats:sec>\n            <jats:title>Background:<\/jats:title>\n            <jats:p>The intervention of gonadotropin-releasing hormone agonist or in combination with recombinant human growth hormone (rhGH) is still controversial for children with central precocious puberty (CPP) or early puberty (EP). This study aimed to systematically review and compare the efficacy and safety of current therapeutic regimens for CPP or EP based on different timings of intervention.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods:<\/jats:title>\n            <jats:p>We searched 7 databases and 2 registers for available studies from inception until December 2023. Two independent reviewers screened literature, extracted data, and assessed the risk of bias. Eligible data from randomized controlled trials and non-randomized studies of interventions were synthesized with meta-analysis and further performed subgroup analysis.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results:<\/jats:title>\n            <jats:p>A total of 55 studies were included in this review, including 11 randomized controlled trials and 44 non-randomized studies of interventions. The pharmacotherapy was beneficial to final height (FH) for the girls with CPP or EP (for combination therapy: mean difference [MD] 1.58, 95% confidence interval [CI] 0.66\u20132.51; for monotherapy: MD 2.51, 95% CI 1.26\u20133.76), and subgroup analysis showed that CPP with puberty onset aged before 8 years (for combination therapy: MD 3.69, 95% CI 1.59\u20135.79; for monotherapy: MD 4.83, 95% CI 3.29\u20136.17), early intervention before 8 years of age (for combination therapy: MD 3.50, 95% CI 1.75\u20135.25; for monotherapy: MD 6.50, 95% CI 4.99\u20138.01), and the course of combination with rhGH for more than 2 years (MD 3.31, 95% CI 2.14\u20134.47) improved higher FH. The pharmacologic intervention had less impact on the body mass index at FH (MD \u22120.06, 95% CI \u22120.50 to 0.38), but probably increase the risk of the incidence of polycystic ovary syndrome (risk ratio 1.93, 95% CI 1.26\u20132.98) in the long term.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusion:<\/jats:title>\n            <jats:p>The gonadotropin-releasing hormone agonist improved the FH of children with CPP, and in combination with rhGH appeared to further increase the effectiveness of pharmacotherapy. The increasing risk of polycystic ovary syndrome should be considered before treatment and further confirmed through high-quality comparative studies in the future.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/md.0000000000041936","type":"journal-article","created":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T23:00:34Z","timestamp":1754089234000},"page":"e41936","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":7,"title":["Pharmacotherapy for children with central precocious puberty or early puberty: A systematic review and meta-analysis"],"prefix":"10.1097","volume":"104","author":[{"given":"Chunsong","family":"Yang","sequence":"first","affiliation":[{"name":"Department of Pharmacy, West China Second University Hospital, Sichuan University, Chengdu, China"},{"name":"Evidence-Based Pharmacy Center, West China Second University Hospital, Sichuan University, Chengdu, China"},{"name":"NMPA Key Laboratory for Technical Research on Drug Products In Vitro and In Vivo Correlation, Chengdu, China"},{"name":"Key Laboratory of Birth Defects and Related Diseases of Women and Children, Sichuan University, Ministry of Education, Chengdu, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zheng","family":"Liu","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, West China Second University Hospital, Sichuan University, Chengdu, China"},{"name":"Evidence-Based Pharmacy Center, West China Second University Hospital, Sichuan University, Chengdu, China"},{"name":"NMPA Key Laboratory for Technical Research on Drug Products In Vitro and In Vivo Correlation, Chengdu, China"},{"name":"Key Laboratory of Birth Defects and Related Diseases of Women and Children, Sichuan University, Ministry of Education, Chengdu, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linan","family":"Zeng","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, West China Second University Hospital, Sichuan University, Chengdu, China"},{"name":"Evidence-Based Pharmacy Center, West China Second University Hospital, Sichuan University, Chengdu, China"},{"name":"NMPA Key Laboratory for Technical Research on Drug Products In Vitro and In Vivo Correlation, Chengdu, China"},{"name":"Key Laboratory of Birth Defects and Related Diseases of Women and Children, Sichuan University, Ministry of Education, Chengdu, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jin","family":"Wu","sequence":"additional","affiliation":[{"name":"Key Laboratory of Birth Defects and Related Diseases of Women and Children, Sichuan University, Ministry of Education, Chengdu, China"},{"name":"Department of Pediatrics, West China Second University Hospital, Sichuan University, Chengdu, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lingli","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, West China Second University Hospital, Sichuan University, Chengdu, China"},{"name":"Evidence-Based Pharmacy Center, West China Second University Hospital, Sichuan University, Chengdu, China"},{"name":"NMPA Key Laboratory for Technical Research on Drug Products In Vitro and In Vivo Correlation, Chengdu, China"},{"name":"Key Laboratory of Birth Defects and Related Diseases of Women and Children, Sichuan University, Ministry of Education, Chengdu, China"},{"name":"Laboratory of Molecular Translational Medicine, Center for Translational Medicine, Sichuan University, Chengdu, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20250918","doi-asserted-by":"crossref","first-page":"3073","DOI":"10.1007\/s00431-021-04022-1","article-title":"Diagnosis and management of precocious sexual maturation: an updated review.","volume":"180","author":"Cheuiche","year":"2021","journal-title":"Eur J Pediatr"},{"key":"R2-20250918","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/j.jpeds.2018.12.022","article-title":"Incidence and prevalence of central precocious puberty in Korea: an epidemiologic study based on a national database.","volume":"208","author":"Kim","year":"2019","journal-title":"J Pediatr"},{"key":"R3-20250918","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.1542\/peds.2005-0012","article-title":"Prevalence and incidence of precocious pubertal development in Denmark: an epidemiologic study based on national registries.","volume":"116","author":"Teilmann","year":"2005","journal-title":"Pediatrics"},{"key":"R4-20250918","doi-asserted-by":"crossref","first-page":"e195881","DOI":"10.1001\/jamapediatrics.2019.5881","article-title":"Worldwide secular trends in age at pubertal onset assessed by breast development among girls: a systematic review and meta-analysis.","volume":"174","author":"Eckert-Lind","year":"2020","journal-title":"JAMA Pediatrics"},{"key":"R5-20250918","doi-asserted-by":"crossref","first-page":"e2015665","DOI":"10.1001\/jamanetworkopen.2020.15665","article-title":"Trends in the incidence of central precocious puberty and normal variant puberty among children in Denmark, 1998 to 2017.","volume":"3","author":"Br\u00e4uner","year":"2020","journal-title":"JAMA Network Open"},{"key":"R6-20250918","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1159\/000501336","article-title":"Use of gonadotropin-releasing hormone analogs in children: update by an international consortium.","volume":"91","author":"Bangalore Krishna","year":"2019","journal-title":"Horm Res Paediatr"},{"key":"R7-20250918","first-page":"16","article-title":"Expert consensus on the diagnosis and treatment of central precocious puberty (2022).","volume":"61","year":"2023","journal-title":"Chin J Pediatr"},{"key":"R8-20250918","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1053\/beem.2001.0187","article-title":"Early puberty in girls.","volume":"16","author":"Mul","year":"2002","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"key":"R9-20250918","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1093\/humupd\/dmh012","article-title":"Precocious puberty and statural growth.","volume":"10","author":"Carel","year":"2004","journal-title":"Hum Reprod Update"},{"key":"R10-20250918","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1111\/cen.14214","article-title":"Adult height after gonadotropin-releasing hormone agonist treatment in girls with early puberty: a meta-analysis.","volume":"93","author":"Park","year":"2020","journal-title":"Clin Endocrinol (Oxf)"},{"key":"R11-20250918","doi-asserted-by":"crossref","first-page":"e752","DOI":"10.1542\/peds.2008-1783","article-title":"Consensus statement on the use of gonadotropin-releasing hormone analogs in children.","volume":"123","author":"Carel","year":"2009","journal-title":"Pediatrics"},{"key":"R12-20250918","doi-asserted-by":"crossref","first-page":"e0185080","DOI":"10.1371\/journal.pone.0185080","article-title":"Improved final predicted height with the injection of leuprolide in children with earlier puberty: a retrospective cohort study.","volume":"12","author":"Lin","year":"2017","journal-title":"PLoS One"},{"key":"R13-20250918","first-page":"361","article-title":"Effect of gonadotropin-releasing hormone analog treatment on final height in girls aged 6\u201310 years with central precocious and early puberty.","volume":"55","author":"Onat","year":"2020","journal-title":"Turk Pediatri Arsivi"},{"key":"R14-20250918","doi-asserted-by":"crossref","first-page":"3575","DOI":"10.1210\/jcem.84.10.6032","article-title":"Lack of effect of GnRH agonists on final height in girls with advanced puberty: a randomized long-term pilot study.","volume":"84","author":"Bouvattier","year":"1999","journal-title":"J Clin Endocrinol Metab"},{"key":"R15-20250918","doi-asserted-by":"crossref","first-page":"133","DOI":"10.14740\/jocmr3710","article-title":"The gonadotropin-releasing hormone analogue therapy may not impact final height in precocious puberty of girls with onset of puberty aged 6 - 8 years.","volume":"11","author":"Korkmaz","year":"2019","journal-title":"J Clin Med Res"},{"key":"R16-20250918","doi-asserted-by":"crossref","first-page":"211","DOI":"10.4274\/jcrpe.2356","article-title":"Gonadotropin-releasing hormone analogue treatment in females with moderately early puberty: no effect on final height.","volume":"8","author":"Sava\u015f-Erdeve","year":"2016","journal-title":"J Clin Res Pediatr Endocrinol"},{"key":"R17-20250918","doi-asserted-by":"crossref","first-page":"267","DOI":"10.4103\/2230-8210.131770","article-title":"Effect of gonadotropin-releasing hormone agonist therapy on body mass index and growth in girls with idiopathic central precocious puberty.","volume":"19","author":"Anik","year":"2015","journal-title":"Indian J Endocrinol Metab"},{"key":"R18-20250918","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1515\/jpem-2018-0290","article-title":"One-year treatment with gonadotropin-releasing hormone analogues does not affect body mass index, insulin sensitivity or lipid profile in girls with central precocious puberty.","volume":"32","author":"Arcari","year":"2019","journal-title":"J Pediatr Endocrinol Metab"},{"key":"R19-20250918","doi-asserted-by":"crossref","first-page":"27","DOI":"10.6065\/apem.2017.22.1.27","article-title":"Change in body mass index and insulin resistance after 1-year treatment with gonadotropin-releasing hormone agonists in girls with central precocious puberty.","volume":"22","author":"Park","year":"2017","journal-title":"Ann Pediatr Endocrinol Metab"},{"key":"R20-20250918","doi-asserted-by":"crossref","first-page":"816635","DOI":"10.3389\/fped.2022.816635","article-title":"Do GnRH agonists really increase body weight gain? Evaluation of a multicentric Portuguese cohort of patients with central precocious puberty.","volume":"10","author":"Leite","year":"2022","journal-title":"Front Pediatr"},{"key":"R21-20250918","doi-asserted-by":"crossref","first-page":"1369","DOI":"10.1515\/jpem-2019-0136","article-title":"Near final adult height, and body mass index in overweight\/obese and normal-weight children with idiopathic central precocious puberty and treated with gonadotropin-releasing hormone analogs.","volume":"32","author":"Sinthuprasith","year":"2019","journal-title":"J Pediatr Endocrinol Metab"},{"key":"R23-20250918","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1530\/EJE-09-1102","article-title":"GNRH analog therapy in girls with early puberty is associated with the achievement of predicted final height but also with increased risk of polycystic ovary syndrome.","volume":"163","author":"Chiavaroli","year":"2010","journal-title":"Eur J Endocrinol"},{"key":"R24-20250918","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1186\/s40842-021-00129-4","article-title":"Gonadotropin releasing hormone analogue treatment of central precocious puberty is not associated with altered prevalence of polycystic ovary syndrome: a single center cohort study.","volume":"7","author":"Karavani","year":"2021","journal-title":"Clin Diabetes Endocrinol"},{"key":"R25-20250918","first-page":"948","article-title":"Combined treatment with gonadotropin-releasing hormone analog and growth hormone in central precocious puberty.","volume":"81","author":"Pasquino","year":"1996","journal-title":"J Clin Endocrinol Metab"},{"key":"R26-20250918","doi-asserted-by":"crossref","first-page":"1264","DOI":"10.1038\/s41598-023-28602-3","article-title":"Effect of gonadotropin-releasing hormone agonist monotherapy and combination therapy with growth hormone on final adult height in girls with central precocious puberty.","volume":"13","author":"Cho","year":"2023","journal-title":"Sci Rep"},{"key":"R27-20250918","doi-asserted-by":"crossref","first-page":"214","DOI":"10.6065\/apem.2014.19.4.214","article-title":"Adult height in girls with central precocious puberty treated with gonadotropin-releasing hormone agonist with or without growth hormone.","volume":"19","author":"Jung","year":"2014","journal-title":"Ann Pediatr Endocrinol Metab"},{"key":"R28-20250918","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1515\/jpem-2014-0305","article-title":"Effect of GnRHa 3.75 mg subcutaneously every 6 weeks on adult height in girls with idiopathic central precocious puberty.","volume":"28","author":"Liang","year":"2015","journal-title":"J Pediatr Endocrinol Metab"},{"key":"R29-20250918","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3345\/kjp.2015.58.1.1","article-title":"Long-term effects of gonadotropin-releasing hormone analogs in girls with central precocious puberty.","volume":"58","author":"Kim","year":"2015","journal-title":"Korean J Pediatr"},{"key":"R30-20250918","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1111\/j.1651-2227.2004.tb02683.x","article-title":"Onset of puberty at eight years of age in girls determines a specific tempo of puberty but does not affect adult height.","volume":"93","author":"Llop-Vi\u00f1olas","year":"2004","journal-title":"Acta Paediatr"},{"key":"R31-20250918","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1007\/s00431-017-2898-8","article-title":"Adult height after spontaneous pubertal growth or GnRH analog treatment in girls with early puberty: a meta-analysis.","volume":"176","author":"Bertelloni","year":"2017","journal-title":"Eur J Pediatr"},{"key":"R32-20250918","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1007\/s40618-016-0486-9","article-title":"Effects and safety of combination therapy with gonadotropin-releasing hormone analogue and growth hormone in girls with idiopathic central precocious puberty: a meta-analysis.","volume":"39","author":"Liu","year":"2016","journal-title":"J Endocrinol Invest"},{"key":"R34-20250918","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1111\/cen.14410","article-title":"Long-term efficacy and safety of gonadotropin-releasing hormone analog treatment in children with idiopathic central precocious puberty: a systematic review and meta-analysis.","volume":"94","author":"Luo","year":"2021","journal-title":"Clin Endocrinol (Oxf)"},{"key":"R35-20250918","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1530\/EJE-18-0473","article-title":"GnRH analog is ineffective in increasing adult height in girls with puberty onset after 7 years of age: a systematic review and meta-analysis.","volume":"179","author":"Franzini","year":"2018","journal-title":"Eur J Endocrinol"},{"key":"R36-20250918","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1210\/jcem.87.2.8202","article-title":"Longitudinal follow-up of bone density and body composition in children with precocious or early puberty before, during and after cessation of GnRH agonist therapy.","volume":"87","author":"van der Sluis","year":"2002","journal-title":"J Clin Endocrinol Metab"},{"key":"R37-20250918","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1210\/jc.2009-0178","article-title":"Long-term safety of recombinant human growth hormone in children.","volume":"95","author":"Bell","year":"2010","journal-title":"J Clin Endocrinol Metab"},{"key":"R38-20250918","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1210\/jc.2006-2012","article-title":"Clinical review: identifying children at risk for polycystic ovary syndrome.","volume":"92","author":"Rosenfield","year":"2007","journal-title":"J Clin Endocrinol Metab"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000041936","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,18]],"date-time":"2025-09-18T22:00:38Z","timestamp":1758232838000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000041936"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,1]]},"references-count":36,"journal-issue":{"issue":"31","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000041936","relation":{},"ISSN":["1536-5964"],"issn-type":[{"value":"1536-5964","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,8,1]]},"assertion":[{"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-02-16","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}